Sarnelli, G., Seguella, L., Pesce, M., Lu, J., Gigli, S., Bruzzese, E., . . . Esposito, G. (2018). HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia. BMC.
Chicago Style (17th ed.) CitationSarnelli, Giovanni, et al. HIV-1 Tat-induced Diarrhea Is Improved by the PPARalpha Agonist, Palmitoylethanolamide, by Suppressing the Activation of Enteric Glia. BMC, 2018.
MLA (8th ed.) CitationSarnelli, Giovanni, et al. HIV-1 Tat-induced Diarrhea Is Improved by the PPARalpha Agonist, Palmitoylethanolamide, by Suppressing the Activation of Enteric Glia. BMC, 2018.
Warning: These citations may not always be 100% accurate.